Novo CEO Sees 'Positive Growth on the Other Side of the Business'
February 3, 2026
2,242
29
3
1.43%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Bloomberg Podcasts Episodes Around February 3, 2026
See what was published immediately before and after this episode.
8:55Now PlayingNovo CEO Sees 'Positive Growth on the Other Side of the Business'
YouTube Description
as posted by the channelNovo Nordisk CEO Mike Doustdar discusses the company's updated 2026 sales guidance, forecasting a decline of 5 to 13% at constant exchange rates. Doustdar highlights the strong uptake of Novo Nordisk's oral GLP-1 treatment Wegovy, which has reached over 170,000 patients within four weeks of launch. The company expects sales will fall by as much as 13% this year. Pressure from lower prices for its blockbuster weight-loss drugs, in part due to the US government’s push to cut drug prices in country, will contribute to the decline, the company said. The warning reflects the challenges facing Novo as it contends with mounting competition in the fast-growing market for weight-loss drugs, battling Eli Lilly & Co. to gain market share as well as telehealth companies sellling copycat versions of their drugs at even cheaper prices. It also highlights how drugmakers are under pressure from President Donald Trump to lower pharmaceutical costs for many Americans.
--------
Follow Bloomberg for business news & analysis, uptotheminute market data, features, profiles and more
Connect with us on...
Links & Promotions
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.